Analysis
Krystal Biotech Surpasses Expectations as VYJUVEK Drives Record 2025 Revenue and International Expansion
Krystal Biotech, Inc. (NASDAQ: KRYS), a leader in redosable gene therapies, today announced record-breaking financial results for the fourth quarter...